Inhibikase Therapeutics (IKT) Debt to Equity (2020 - 2025)
Inhibikase Therapeutics (IKT) reported Debt to Equity of $0.0 for Q2 2025, down 98.41% year-over-year from $0.03 in Q2 2024, and down 45.66% quarter-over-quarter from $0.0 in Q1 2025.
Inhibikase Therapeutics (IKT) Debt to Equity (2020 - 2025) Analysis & Trends
Inhibikase Therapeutics (IKT) has 6 years of Debt to Equity data on file, last reported at $0.0 in Q2 2025.
- Debt to Equity for Q2 2025 came in at $0.0, down 98.41% year-over-year; the trailing twelve-month figure through Jun 2025 was $0.0 (down 98.41% YoY), and the FY2024 annual result was $0.0, down 91.48% from the prior year.
- Debt to Equity declined to $0.0 in Q2 2025 per IKT's latest filing, from $0.0 in the prior quarter.
- Over five years, Debt to Equity peaked at $0.03 in Q1 2021 and troughed at -$0.27 in Q3 2024.
- A 5-year average of -$0.01 and a median of $0.01 in 2023 frame the typical range for Debt to Equity.
- On a YoY basis, Debt to Equity climbed as much as 292.9% in 2024 and fell as far as 2857.86% in 2024.
- A 5-year view of Debt to Equity shows it stood at $0.01 in 2021, then surged by 31.06% to $0.01 in 2022, then surged by 97.21% to $0.01 in 2023, then plunged by 91.48% to $0.0 in 2024, then sank by 59.31% to $0.0 in 2025.
- Business Quant data shows IKT's Debt to Equity at $0.0 in Q2 2025, $0.0 in Q1 2025, and $0.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Inhibikase Therapeutics | 285.17 Mn | 114.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | -0.27 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.03 |
| Dec 31, 2020 | 0.03 |